MarketPeel
Insider Trading Intelligence
FH

Frank A. Holler

XENE
DIRECTOR · XENON PHARMACEUTICALS INC. · CIK 0000938801
FILING MIX · LIFETIME36%/64%
BUYS
4
SELLS
7
TOTAL VALUE
$485.9K
COMPANIES
1
ACTIVE SINCE
May 2020
HOLDINGS NOW
0
AVG SELL PX
$18.75
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Frank A. Holler, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%-1.85%-0.12%-1.73%-1.73%
14d2+0.00%+0.48%+1.03%-0.55%-0.55%
30d2+100.00%-1.69%+2.08%-3.77%-3.77%
60d2+100.00%-5.18%+5.53%-10.71%-10.71%
90d2+100.00%-10.10%+7.41%-17.51%-17.51%
180d2+0.00%+48.44%+12.39%+36.05%+36.05%
1y2+0.00%+45.37%+0.34%+45.03%+45.03%
2y2+0.00%+112.00%+3.22%+108.79%+108.79%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
XENE · 0 shares · as of May 27, 2021
040,15780,314120,471160,6282021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
FLOW · 4 buys / 7 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
XENE
XENON PHARMACEUTICALS INC.
SALE
2,579$18.69$48.2K152,138May 27, 2021Jun 1, 2021
XENE
XENON PHARMACEUTICALS INC.
SALE
507$18.88$9.6K124,620May 27, 2021Jun 1, 2021
XENE
XENON PHARMACEUTICALS INC.
SALE
3,0860May 27, 2021Jun 1, 2021
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
3,086$3.76$11.6K125,127May 27, 2021Jun 1, 2021
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
36,008$3.76$135.4K160,628May 27, 2021Jun 1, 2021
XENE
XENON PHARMACEUTICALS INC.
SALE
5,911$18.88$111.6K154,717May 27, 2021Jun 1, 2021
XENE
XENON PHARMACEUTICALS INC.
SALE
8,485$18.68$158.5K143,653May 27, 2021Jun 1, 2021
XENE
XENON PHARMACEUTICALS INC.
SALE
36,0080May 27, 2021Jun 1, 2021
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
10,00010,000Jun 1, 2020Jun 2, 2020
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
3,086$3.56$11.0K122,041May 29, 2020Jun 2, 2020
XENE
XENON PHARMACEUTICALS INC.
SALE
3,0860May 29, 2020Jun 2, 2020
Other insiders · XENE
Loading peer insiders…
About this filer
CIK 0000938801
ROLE
Director
PRIMARY
XENE
COMPANIES
1
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0000938801DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback